Les Meilleurs doctors pour le traitement de lymphome de Hodgkin en Israël - TOP-19 des médecins

Chef du service d'hématologie du centre médical Sourasky, il dirige l'équipe de l'hôpital pour les soins liés aux cancers du sang.

• Plus de 25 ans d'expérience en tant qu'hématologue
• Formation spécialisée au prestigieux centre Ronald O Perelman et Claudia Cohen
• Spécialisé dans les cancers du sang tels que le lymphome de Hodgkin
• Titulaire d'un diplôme de médecine de l'université de Mysore

A réalisé plusieurs centaines de greffes de cellules souches – le Dr Ram se spécialise dans les cas complexes nécessitant cette procédure avancée au centre médical Sourasky.

• Certifié en hématologie, en oncologie médicale et en médecine interne
• Auteur de plus de 30 articles scientifiques et d'un chapitre de manuel médical
• A effectué son clinicat au New York Medical College et au Westchester Medical Center
• Se concentre exclusivement sur les cancers hématologiques

Le Dr Ronit El Hasid a réalisé plus de 300 transplantations pédiatriques de moelle osseuse et de sang de cordon ombilical, dirigeant le service de l'hôpital pour enfants Dana Dwek de Sourasky.

• Se spécialiser en oncologie pédiatrique avec un accent sur les procédures de transplantation
• Publier plus de 50 articles de recherche et 40 rapports de conférence
• Se former à l'hôpital City of Hope de Los Angeles
• Membre des sociétés d'hématologie américaine et israélienne

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Le Dr Shapira travaille au service de transplantation de moelle osseuse du centre médical Sourasky – un traitement essentiel pour le lymphome de Hodgkin.

• Spécialisé en greffe de moelle osseuse depuis son poste de direction à l'hôpital Hadassah
• Formé en médecine interne au prestigieux centre médical Hadassah
• Diplômé de l'Université hébraïque, l'une des meilleures facultés de médecine d'Israël

Le Dr Aviv apporte 31 ans d'expérience dévouée dans le traitement des cancers du sang au célèbre centre médical Sourasky (Ichilov).

• Il est spécialiste en onco-hématologie – le domaine des cancers du sang et de la moelle osseuse
• Il propose des consultations en ligne pour une évaluation à distance
• Sa longue carrière s'est déroulée dans l'un des principaux centres médicaux d'Israël

Le Dr Dror Levin est un expert de premier plan en hématologie-oncologie pédiatrique au Sourasky Medical Center, spécialisé dans les troubles sanguins et le cancer des os chez les enfants.

• Directeur du département d'hématologie-oncologie pédiatrique au Sourasky Medical Center
• A suivi une formation spécialisée à l'Institut Orthopédique Rizzoli – un leader mondial en oncologie osseuse
• Membre de l'association israélienne d'hémato-oncologie pédiatrique ISPHO
• Coordonner le traitement multidisciplinaire des sarcomes de l'enfant

Le Dr Herishanu Yair a reçu de nombreux prix prestigieux pour ses recherches en hématologie et son excellence clinique au centre médical Sourasky de Tel-Aviv.

• Se spécialiser dans le traitement de la leucémie lymphoïde chronique
• Être lauréat du prix d'oncologie Klitzberg
• Être membre des associations israélienne et américaine d'hématologie
• Suivre une formation approfondie en hématologie dans les principaux centres médicaux israéliens

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Ofer Spielberg est un onco-hématologue spécialisé dans les cancers du sang au centre médical Assuta.

• Se concentrer exclusivement sur le traitement des troubles sanguins et des cancers
• Être expert dans les derniers traitements pour des pathologies telles que le lymphome de Hodgkin
• Fournir des plans de traitement personnalisés pour les maladies sanguines complexes

Le professeur Zila Zuckerman est spécialisée en hématologie et en transplantologie au centre médical Rambam.

• Experte dans le traitement des cancers du sang, y compris le lymphome de Hodgkin
• Spécialisée dans les techniques de transplantation avancées
• Travaille dans l'un des principaux centres médicaux d'Israël

Spécialisée en radiothérapie et en oncologie, le Dr Karen Drumea propose des soins experts au centre médical Rambam.

• Élaborer des plans de traitement personnalisés pour le lymphome de Hodgkin
• Posséder une vaste expérience des techniques de radiothérapie
• Être affiliée au centre médical Rambam – un établissement de santé de premier plan

Spécialiste en hématologie avec une concentration sur les lymphomes, y compris le lymphome de Hodgkin, au centre médical Rambam.

• Expertise dans le traitement des cas de lymphome de Hodgkin
• Spécialisé en hématologie avec un accent sur les maladies lymphoprolifératives
• Associé au centre médical Rambam, un hôpital de premier plan en Israël